The GenomeMET project Overview

Cancer is a major burden on European society. Advances in genomics, driven by technologies such as Next Generation Sequencing (NGS) are transforming cancer care, enabling earlier and more accurate diagnosis, guiding therapy selection and driving development of targeted therapies (precision medicine), which improves patient outcomes and health system effectiveness.

 

However, the quality and comparability of genomic profiling currently varies significantly and development of standards and metrological means to support the field are in their infancy. This project aims to address these needs by applying metrological principles to develop reference measurement systems  to support cancer genomic diagnostics in compliance with the In-vitro Diagnostic Device Regulation (IVDR EU 2017/746).